These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 11508619)

  • 41. The study of tamoxifen and raloxifene: preliminary enrollment data from a randomized breast cancer risk reduction trial.
    Vogel VG; Costantino JP; Wickerham DL; Cronin WM; Wolmark N
    Clin Breast Cancer; 2002 Jun; 3(2):153-9. PubMed ID: 12123540
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.
    Vogel VG; Costantino JP; Wickerham DL; Cronin WM; Cecchini RS; Atkins JN; Bevers TB; Fehrenbacher L; Pajon ER; Wade JL; Robidoux A; Margolese RG; James J; Lippman SM; Runowicz CD; Ganz PA; Reis SE; McCaskill-Stevens W; Ford LG; Jordan VC; Wolmark N;
    JAMA; 2006 Jun; 295(23):2727-41. PubMed ID: 16754727
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tamoxifen and breast cancer--from palliation to prevention.
    Rich SE
    Cancer Nurs; 1993 Oct; 16(5):341-6. PubMed ID: 7505194
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reducing the risk of breast cancer with tamoxifen in women at increased risk.
    Vogel VG
    J Clin Oncol; 2001 Sep; 19(18 Suppl):87S-92S. PubMed ID: 11560980
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessment of Breast Cancer Patients' Knowledge and Decisional Conflict Regarding Tamoxifen Use.
    Kim SI; Lee Y; Son Y; Jun SY; Yun S; Bae HS; Lim MC; Jung SY; Joo J; Lee ES
    J Korean Med Sci; 2015 Nov; 30(11):1604-10. PubMed ID: 26539004
    [TBL] [Abstract][Full Text] [Related]  

  • 46. News media coverage of screening mammography for women in their 40s and tamoxifen for primary prevention of breast cancer.
    Schwartz LM; Woloshin S
    JAMA; 2002 Jun; 287(23):3136-42. PubMed ID: 12069679
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Factors implicated in the decision whether or not to join the tamoxifen trial in women at high familial risk of breast cancer.
    Lovegrove E; Rumsey N; Harcourt D; Cawthorn SJ
    Psychooncology; 2000; 9(3):193-202. PubMed ID: 10871715
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk-benefit profiles of women using tamoxifen for chemoprevention.
    Nichols HB; DeRoo LA; Scharf DR; Sandler DP
    J Natl Cancer Inst; 2015 Jan; 107(1):354. PubMed ID: 25475563
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Women's decisions regarding tamoxifen for breast cancer prevention: responses to a tailored decision aid.
    Fagerlin A; Zikmund-Fisher BJ; Nair V; Derry HA; McClure JB; Greene S; Stark A; Hensley Alford S; Lantz P; Hayes DF; Wiese C; Claud Zweig S; Pitsch R; Jankovic A; Ubel PA
    Breast Cancer Res Treat; 2010 Feb; 119(3):613-20. PubMed ID: 19908143
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
    Chin J; Konje JC; Hickey M
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007245. PubMed ID: 19821400
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
    Lancet; 1998 May; 351(9114):1451-67. PubMed ID: 9605801
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Providing accurate information to women about tamoxifen therapy for breast cancer: current indications, effects, and controversies.
    Pasacreta JV; McCorkle R
    Oncol Nurs Forum; 1998 Oct; 25(9):1577-83. PubMed ID: 9802053
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Italian randomized trial among women with hysterectomy: tamoxifen and hormone-dependent breast cancer in high-risk women.
    Veronesi U; Maisonneuve P; Rotmensz N; Costa A; Sacchini V; Travaglini R; D'Aiuto G; Lovison F; Gucciardo G; Muraca MG; Pizzichetta MA; Conforti S; Decensi A; Robertson C; Boyle P;
    J Natl Cancer Inst; 2003 Jan; 95(2):160-5. PubMed ID: 12529349
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tamoxifen therapy for breast cancer and endometrial cancer risk.
    Bernstein L; Deapen D; Cerhan JR; Schwartz SM; Liff J; McGann-Maloney E; Perlman JA; Ford L
    J Natl Cancer Inst; 1999 Oct; 91(19):1654-62. PubMed ID: 10511593
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors.
    Fisher B; Dignam J; Bryant J; DeCillis A; Wickerham DL; Wolmark N; Costantino J; Redmond C; Fisher ER; Bowman DM; Deschênes L; Dimitrov NV; Margolese RG; Robidoux A; Shibata H; Terz J; Paterson AH; Feldman MI; Farrar W; Evans J; Lickley HL
    J Natl Cancer Inst; 1996 Nov; 88(21):1529-42. PubMed ID: 8901851
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Breast cancer chemoprevention: risk-benefit effects of the antioestrogen tamoxifen.
    Brown K
    Expert Opin Drug Saf; 2002 Sep; 1(3):253-67. PubMed ID: 12904141
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of tamoxifen on the endometrium.
    Barakat RR
    Oncology (Williston Park); 1995 Feb; 9(2):129-34; discussion 139-40, 142. PubMed ID: 8771096
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer.
    Gail MH; Costantino JP; Bryant J; Croyle R; Freedman L; Helzlsouer K; Vogel V
    J Natl Cancer Inst; 1999 Nov; 91(21):1829-46. PubMed ID: 10547390
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chemoprevention of breast cancer.
    Osborne MP
    Surg Clin North Am; 1999 Oct; 79(5):1207-21. PubMed ID: 10572559
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardiovascular effects of tamoxifen in women with and without heart disease: breast cancer prevention trial. National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial Investigators.
    Reis SE; Costantino JP; Wickerham DL; Tan-Chiu E; Wang J; Kavanah M
    J Natl Cancer Inst; 2001 Jan; 93(1):16-21. PubMed ID: 11136837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.